A recent landmark clinical trial published in The Lancet demonstrates that combination inhalers significantly reduce asthma attacks in children by nearly 50%, outperforming traditional salbutamol-only inhalers. Conducted across multiple hospitals, the CARE study presents compelling evidence supporting shifts in pediatric asthma management to improve outcomes and reduce hospitalization rates.